Radiomics machine learning algorithm facilitates detection of small pancreatic neuroendocrine tumors on CT

被引:0
|
作者
Lopez-Ramirez, Felipe [1 ]
Soleimani, Sahar [1 ]
Azadi, Javad R. [1 ]
Sheth, Sheila [1 ,2 ]
Kawamoto, Satomi [1 ]
Javed, Ammar A. [3 ]
Tixier, Florent [1 ]
Hruban, Ralph H. [4 ,5 ]
Fishman, Elliot K. [1 ]
Chu, Linda C. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21287 USA
[2] NYU, Grossman Sch Med, Dept Radiol, New York, NY 10016 USA
[3] NYU, Grossman Sch Med, Dept Surg, New York, NY 10016 USA
[4] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Sch Med, Baltimore, MD 21287 USA
[5] Johns Hopkins Univ, Sol Goldman Pancreat Canc Res Ctr, Sch Med, Dept Pathol, Baltimore, MD 21287 USA
关键词
Artificial intelligence; Automated screening; Computed tomography; Pancreatic neuroendocrine tumors; Radiomics; SEGMENTATION;
D O I
10.1016/j.diii.2024.08.003
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: The purpose of this study was to develop a radiomics-based algorithm to identify small pancreatic neuroendocrine tumors (PanNETs) on CT and evaluate its robustness across manual and automated segmentations, exploring the feasibility of automated screening. Materials and methods: Patients with pathologically confirmed T1 stage PanNETs and healthy controls undergoing dual-phase CT imaging were retrospectively identified. Manual segmentation of pancreas and tumors was performed, then automated pancreatic segmentations were generated using a pretrained neural network. A total of 1223 radiomics features were independently extracted from both segmentation volumes, in the arterial and venous phases separately. Ten final features were selected to train classifiers to identify PanNETs and controls. The cohort was divided into training and testing sets, and performance of classifiers was assessed using area under the receiver operator characteristic curve (AUC), specificity and sensitivity, and compared against two radiologists blinded to the diagnoses. Results: A total of 135 patients with 142 PanNETs, and 135 healthy controls were included. There were 168 women and 102 men, with a mean age of 55.4 11.6 (standard deviation) years (range: 20-85 years). Median PanNET size was 1.3 cm (Q1, 1.0; Q3, 1.5; range: 0.5-1.9). The arterial phase LightGBM model achieved the best performance in the test set, with 90% sensitivity (95% confidence interval [CI]: 80-98), 76% specificity (95% CI: 62-88) and an AUC of 0.87 (95% CI: 0.79-0.94). Using features from the automated segmentations, this model achieved an AUC of 0.86 (95% CI: 0.79-0.93). In comparison, the two radiologists achieved a mean 50% sensitivity and 100% specificity using arterial phase CT images. Conclusion: Radiomics features identify small PanNETs, with stable performance when extracted using automated segmentations. These models demonstrate high sensitivity, complementing the high specificity of radiologists, and could serve as opportunistic screeners. (c) 2024 Soci & eacute;t & eacute; fran & ccedil;aise de radiologie. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:28 / 40
页数:13
相关论文
共 50 条
  • [31] A combined nomogram to predict liver metastasis of pancreatic neuroendocrine tumors: Integrating deep learning radiomics and computational pathology
    Huang, D.
    Tang, W.
    Ma, M.
    Liang, Y.
    JOURNAL OF NEUROENDOCRINOLOGY, 2024, 36 : 143 - 143
  • [32] CT-Based Radiomics Score for Distinguishing Between Grade I and Grade 2 Nonfunctioning Pancreatic Neuroendocrine Tumors
    Bian, Yun
    Jiang, Hui
    Ma, Chao
    Wang, Li
    Zheng, Jianming
    Jin, Gang
    Lu, Jianping
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2020, 215 (04) : 852 - 863
  • [33] Editorial for "Noncontrast Radiomics Approach for Predicting Grades of Nonfunctional Pancreatic Neuroendocrine Tumors"
    Izumiya, Masashi
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2020, 52 (04) : 1137 - 1138
  • [34] A Radiomics Nomogram Model to Preoperatively Predict Histologic Grade in Pancreatic Neuroendocrine Tumors
    Yang, P.
    Xu, L.
    Huang, R.
    Jiang, Y.
    Yang, C.
    Xue, Y.
    Niu, T.
    MEDICAL PHYSICS, 2018, 45 (06) : E564 - E565
  • [35] Stereotactic Radiotherapy for Patients with Small Pancreatic Neuroendocrine Tumors
    Gonzalez, M. Lopez
    Sanchez, E.
    Hernando, O.
    Ciervide, R.
    Montero, A.
    Chen, X.
    Alvarez, B.
    De Vicente, E.
    Quijano, Y.
    Rubio, C.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1114 - S1114
  • [36] Clinicopathological features of small nonfunctioning pancreatic neuroendocrine tumors
    Mariko Furukori
    Koji Imai
    Hidenori Karasaki
    Kenji Watanabe
    Kensuke Oikawa
    Naoyuki Miyokawa
    Masahiko Taniguchi
    Hiroyuki Furukawa
    World Journal of Gastroenterology, 2014, 20 (47) : 17949 - 17954
  • [37] Non-invasive diagnosis model for pancreatic cystic tumors based on machine learning-radiomics using contrast-enhanced CT
    Yang, F.
    Yang, P.
    Yang, M.
    Zhuo, J.
    Wang, J.
    Lu, D.
    Zheng, S.
    Niu, T.
    Xu, X.
    TRANSPLANTATION, 2019, 103 (08) : 344 - 344
  • [38] Small Pancreatic and Periampullary Neuroendocrine Tumors: Resect or Enucleate?
    Pitt, Susan C.
    Pitt, Henry A.
    Baker, Marshall S.
    Christians, Kathleen
    Touzios, John G.
    Kiely, James M.
    Weber, Sharon M.
    Wilson, Stuart D.
    Howard, Thomas J.
    Talamonti, Mark S.
    Rikkers, Layton F.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2009, 13 (09) : 1692 - 1698
  • [39] Surgical strategies for small sporadic neuroendocrine pancreatic tumors
    Holzer, K.
    CHIRURG, 2018, 89 (06): : 422 - 427
  • [40] Clinicopathological features of small nonfunctioning pancreatic neuroendocrine tumors
    Furukori, Mariko
    Imai, Koji
    Karasaki, Hidenori
    Watanabe, Kenji
    Oikawa, Kensuke
    Miyokawa, Naoyuki
    Taniguchi, Masahiko
    Furukawa, Hiroyuki
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (47) : 17949 - 17954